المؤلفون: Sepe P, Mennitto A, Corti F, Procopio G

المصدر: ImmunoTargets and Therapy, Vol Volume 9, Pp 273-288 (2020)

مصطلحات موضوعية: metastatic renal cell carcinoma, immunotherapy, anti-pd-1, anti-ctla-4, targeted therapy, biomarkers, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/immunotherapeutic-targets-and-therapy-for-renal-cell-carcinoma-peer-reviewed-article-ITTTest; https://doaj.org/toc/2253-1556Test

الوصول الحر: https://doaj.org/article/6725adf7196b49c08966a1bc56a013bfTest

المؤلفون: Grassi P, Verzoni E, Ratta R, Mennitto A, de Braud F, Procopio G

المصدر: Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 2167-2172 (2016)

مصطلحات موضوعية: cabozantinib, XL-184, metastatic renal cell carcinoma, VEGF-inhibitor, C-Met, targeted therapy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/cabozantinib-in-the-treatment-of-advanced-renal-cell-carcinoma-design--peer-reviewed-article-DDDTTest; https://doaj.org/toc/1177-8881Test

الوصول الحر: https://doaj.org/article/f3654a1f9952472cb2f83b6181daa5deTest

المؤلفون: P. Grassi, R. Ratta, G. Procopio, E. Verzoni, A. Mennitto, F. de Braud

المساهمون: P. Grassi, E. Verzoni, R. Ratta, A. Mennitto, F. de Braud, G. Procopio

مصطلحات موضوعية: c-Met, Ccbozantinib, metastatic renal cell carcinoma, targeted therapy, VEGF-inhibitor, XL-184, pharmacology, drug discovery3003, pharmaceutical science, Settore MED/06 - Oncologia Medica

الوقت: 3003

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27462141; info:eu-repo/semantics/altIdentifier/wos/WOS:000379332100001; volume:10; firstpage:2167; lastpage:2172; numberofpages:6; journal:DRUG DESIGN, DEVELOPMENT AND THERAPY; http://hdl.handle.net/2434/442270Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978970987

الإتاحة: https://doi.org/10.2147/DDDT.S104225Test
http://hdl.handle.net/2434/442270Test